Hepatitis Forums

Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on December 19, 2018, 10:26:01 am

Title: Mavyret Is Safe for Those With Severely Impaired Kidneys
Post by: Hep Editors on December 19, 2018, 10:26:01 am

AbbVie’s hepatitis C virus (HCV) regimen Mavyret (glecaprevir/pibrentasvir) is safe and highly effective among those with moderate to severe kidney impairment.

Presenting their findings at the Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco, researchers conducted an integrated efficacy and safety analysis of Mavyret among those with Stages 3b, 4 or 5 of chronic kidney disease (CKD), including those on dialysis, who participated in the Phase III EXPEDITION-4 and EXPEDITION-5 studies.

Read more...
https://www.hepmag.com/article/mavyret-safe-severely-impaired-kidneys